Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F20CE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $213,276
Award facts
- Contract value 100% obligated
- $213,275.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections with a ceiling value of $213,275.65 and a firm fixed price structure. This competitive award, which carries no set-aside designation, is expected to be completed by January 2, 2026, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Zepbound is a pharmaceutical product used for weight management and metabolic health, reflecting the Defense Logistics Agency's role in procuring medications to support military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive $999.9 billion pharmaceutical supply vehicle running through December 2026. The parent contract serves as a global pharmaceutical support mechanism enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive federal contract portfolio and has demonstrated capability to meet competitive federal procurement requirements across multiple therapeutic domains and order values.
Quick answers
Who was awarded contract SPE2DR26F20CE?
SPE2DR26F20CE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26F20CE worth?
The government has obligated $213,276 on SPE2DR26F20CE.
Is contract SPE2DR26F20CE an order under another contract?
Yes. SPE2DR26F20CE is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20CE competed?
The extent of competition for SPE2DR26F20CE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award